Key facts
- It has raised $15.7M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Furong Capital, QS Capital, HiMed Fund, Med-Fine Capital, Zeyue Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Endovas Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Endovas Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Endovas Medical
Developer of comprehensive medical solutions for venous diseases. The company develops medical treatment for pulmonary embolism, varicose veins, and other venous diseases, providing patients with more effective cares.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2018
- Website
- endovasmedical.com/
- Ownership
- Privately Held (backing)
Endovas Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Endovas Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Endovas Medical in its N-PORT filings yet. We sweep new filings monthly.